NCT01681069

Efficacy and Safety of IQP-VV-102 in Weight Management

Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate the Safety and Efficacy of IQP-VV-102 in Reducing Body Weight in Overweight and Obese Subjects

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: InQpharm Group · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

Subjects are randomized to either IQP-VV-102 or a matching placebo. Over 12 weeks, the subjects' body weight, body fat and safety parameters are monitored

Conditions

• Obesity
• Overweight

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	IQP-VV-102
OTHER	Placebo

Timeline

• Start date: 2012-10-01
• Primary completion: 2013-06-01
• Completion: 2013-06-01
• First posted: 2012-09-07
• Last updated: 2015-11-06
• Results posted: 2015-11-06

Locations

1 site across 1 country: Germany